Search

everythinglearnresearchcommunity

for

Search:↓

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

LGD1069 effectively prevents breast tumors in mice without toxicity.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Sorafenib can cause a unique skin reaction.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

CTP-543 is generally safe for treating alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

TEDAR is crucial for skin cell differentiation and barrier formation.

JAK inhibitors may help improve symptoms in adults with APECED.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.